Pharmaceuticals

Pentavalent Sector Forecast Shows Robust Momentum, Climbing to $3.39 Billion With 4.7% CAGR

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pentavalent market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Pentavalent Market covering 2026–2035?

The pentavalent market’s size has demonstrated steady growth over recent years. It is anticipated to increase from $2.7 billion in 2025 to $2.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.6%. Historically, this expansion can be linked to factors such as rising infant mortality rates, restricted access to vaccines, the widespread occurrence of rotavirus infections, government-led vaccination initiatives, and global public health campaigns.

The pentavalent market size is projected to demonstrate consistent expansion in the upcoming years, with an expected increase to $3.39 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.7%. The anticipated growth throughout this forecast period stems from advancements in vaccine creation, increased spending in healthcare, the expansion of immunization initiatives in developing nations, alliances between pharmaceutical corporations, and the integration of digital tracking systems for vaccine coverage. Prominent trends for the forecast duration encompass a rise in infant immunization programs, governmental financial support for vaccine innovation, the strengthening of public health infrastructure, heightened awareness regarding rotavirus prevention, and the development of cold chain logistics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Pentavalent Market?

The growing incidence of diphtheria is projected to stimulate expansion in the Pentavalent Market moving ahead. Diphtheria, a severe and highly contagious illness caused by the bacterium Corynebacterium diphtheriae, can lead to serious difficulties with consuming food and breathing, alongside potential skin ulcers. The pentavalent vaccine offers protection to children against diphtheria through a three-dose immunization regimen, thereby increasing the need for these vaccines due to the disease’s rising prevalence. For example, as reported by the European Centre for Disease Prevention and Control in July 2025, a European government agency, in Germany a total of 126 laboratory-confirmed cases of C. diphtheriae ST574 have been identified nationwide, including 55 cases in 2022, 49 in 2023, 18 in 2024, and at least 4 cases in 2025. Consequently, the increasing occurrence of diphtheria is a significant factor propelling the growth of the Pentavalent Market. Increased healthcare spending is anticipated to propel the expansion of the Pentavalent Market. Healthcare expenditure encompasses all financial and other resources dedicated to delivering healthcare services over a defined period. Specifically for pentavalent vaccines, this refers to the funds allocated for the research, manufacturing, distribution, and delivery of immunizations that safeguard against five distinct diseases. For instance, data from the Centers for Medicare & Medicaid Services in December 2024, a US government agency overseeing Medicare and Medicaid programs, indicated that U.S. health care expenditures grew by 7.5% in 2023, reaching $4.9 trillion, which translates to about $14,570 per individual. Consequently, the increase in healthcare expenditure is a significant factor contributing to the Pentavalent Market’s growth.

What Leading Segments Are Studied In The Pentavalent Market?

The pentavalent market covered in this report is segmented –

1) By Type: Pentavalent Vaccines (DTP-HepB-Hib combination), Other Combination Vaccines

2) By Formulation Type: Lyophilized, Liquid

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Pentavalent Vaccines (DTP-HepB-Hib combination): DTP-HepB-Hib (Whole Cell), DTP-HepB-Hib (Acellular)

2) By Other Combination Vaccines: Hexavalent Vaccines

What Industry Trends Are Transforming The Pentavalent Market?

Companies operating in the pentavalent market are concentrating on developing innovative solutions, such as pentavalent immunization vaccines. These vaccines are a type of combination vaccine designed to offer protection against five distinct diseases. For example, in October 2023, Pfizer, a US-based pharmaceutical company, announced that its ‘Penbraya’ pentavalent vaccine received FDA approval. This is the initial and only pentavalent vaccine that provides protection against the five most common meningococcal serogroups—namely A, B, C, W-135, and Y—for individuals aged 10 through 25 years. The vaccine combines elements from the Trumenba meningococcal group B vaccine and the Nimenrix meningococcal groups A, C, W-135, and Y conjugate vaccine. Penbraya has been found to be effective in offering protection against the five meningococcal serogroups responsible for the majority of global invasive meningococcal disease cases.

Which Major Industry Participants Are Leading The Pentavalent Market Growth?

Major companies operating in the pentavalent market are Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Pentavalent Market?

Asia-Pacific was the largest region in the pentavalent market in 2025. The regions covered in the pentavalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pentavalent Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9104&type=smp

Browse Through More Reports Similar to the Global Pentavalent Market 2026, By The Business Research Company

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Quadrivalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795